Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Vrang

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2020
Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db miceMette Simone Aae Madsen, Rikke Veggerby Grønlund, John Eid, et al.
Scientific Reports|February 2, 2022
Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effectFlora Alexopoulou, Esben Matzen Bech, Søren Ljungberg Pedersen, et al.
Molecular Metabolism|July 14, 2017
The endogenous preproglucagon system is not essential for gut growth homeostasis in micePernille Wismann, Pernille Barkholt, Thomas Secher, et al.
Scientific Reports|January 26, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisHelene M Ægidius, Sanne S Veidal, Michael Feigh, et al.
Journal of Medicinal Chemistry|August 4, 2017
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) AnaloguesEsben M Bech, Manuel C Martos-Maldonado, Pernille Wismann, et al.
Scientific Reports|November 1, 2019
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese miceMette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, et al.
The Journal of Endocrinology|May 29, 2010
Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndromeAndreas Nygaard Madsen, Gitte Hansen, Sarah Juel Paulsen, et al.
Molecular Metabolism|February 2, 2021
Whole-brain activation signatures of weight-lowering drugsHenrik H Hansen, Johanna Perens, Urmas Roostalu, et al.
World Journal of Gastroenterology|January 30, 2018
INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitisJonathan D Roth, Michael Feigh, Sanne S Veidal, et al.
Disease Models & Mechanisms|September 8, 2021
Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney diseaseFrederikke E Sembach, Helene M Ægidius, Lisbeth N Fink, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2020
Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db miceMette Simone Aae Madsen, Rikke Veggerby Grønlund, John Eid, et al.
Scientific Reports|February 2, 2022
Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effectFlora Alexopoulou, Esben Matzen Bech, Søren Ljungberg Pedersen, et al.
Molecular Metabolism|July 14, 2017
The endogenous preproglucagon system is not essential for gut growth homeostasis in micePernille Wismann, Pernille Barkholt, Thomas Secher, et al.
Scientific Reports|January 26, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisHelene M Ægidius, Sanne S Veidal, Michael Feigh, et al.
Journal of Medicinal Chemistry|August 4, 2017
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) AnaloguesEsben M Bech, Manuel C Martos-Maldonado, Pernille Wismann, et al.
Scientific Reports|November 1, 2019
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese miceMette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, et al.
The Journal of Endocrinology|May 29, 2010
Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndromeAndreas Nygaard Madsen, Gitte Hansen, Sarah Juel Paulsen, et al.
Molecular Metabolism|February 2, 2021
Whole-brain activation signatures of weight-lowering drugsHenrik H Hansen, Johanna Perens, Urmas Roostalu, et al.
World Journal of Gastroenterology|January 30, 2018
INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitisJonathan D Roth, Michael Feigh, Sanne S Veidal, et al.
Disease Models & Mechanisms|September 8, 2021
Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney diseaseFrederikke E Sembach, Helene M Ægidius, Lisbeth N Fink, et al.
Pageof 10